Clinical Trial

Addressing Hypertension Care in Africa Program

Study acronym: ADHINCRA
Recruiting
View on ClinicalTrials.gov →
Summary
The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-15; most recent amendment 2026-01-13.
Status change: Not Yet Recruiting → Recruiting 2026-01-13
Trial Details
NCT Number NCT06986590
Lead Sponsor Johns Hopkins University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Hypertension, High Blood Pressure
Enrollment 800 participants
Start Date 2026-01-09
Primary Completion 2028-03 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-14